Knockdown of angiopoietin like-2 protects against angiotensin II-induced cerebral endothelial dysfunction in mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 308, Issue 5, 2015, Pages H386-H397

  Yu, Carol ^a,b   Luo, Xiaoyan ^a   Duquette, Natacha ^a   Thorin Trescases, Nathalie ^a   Thorin, Eric ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Angiopoietin like 2; Cerebral arteries; Endothelium; NADPH oxidases; Nitric oxide

Indexed keywords

ACETYLCYSTEINE; ANGIOPOIETIN 2; ANGIOTENSIN II; APOCYNIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROGEN PEROXIDE; INDOMETACIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROSTACYCLIN; PROSTACYCLIN SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; THROMBOXANE A2; TRIACYLGLYCEROL; ACETOPHENONE DERIVATIVE; ACETYLCHOLINE; ANGIOPOIETIN; ANGPTL2 PROTEIN, MOUSE; GLYCOPROTEIN; GP91DS-TAT PROTEIN, CHIMERIC; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOGRAPHY; ARTICLE; BRAIN ARTERY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FLUORESCENCE; GENE SILENCING; INTRACELLULAR SPACE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRESSURIZED ARTERIOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASOCONSTRICTION; VASODILATATION; WILD TYPE; ANIMAL; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG EFFECTS; GENE DELETION; GENETICS; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ACETOPHENONES; ACETYLCHOLINE; ANGIOPOIETINS; ANGIOTENSIN II; ANIMALS; CEREBRAL ARTERIES; ENDOTHELIUM, VASCULAR; GENE DELETION; GLYCOPROTEINS; HYDROGEN PEROXIDE; INDOMETHACIN; MICE; NADPH OXIDASE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; VASOCONSTRICTION;

EID: 84928632133     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00278.2014     Document Type: Article

References (41)

1. Aoi J, Endo M, Kadomatsu T, Miyata K, Nakano M, Horiguchi H, Ogata A, Odagiri H, Yano M, Araki K, Jinnin M, Ito T, Hirakawa S, Ihn H, Oike Y. Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis. Cancer Res 71: 7502–7512, 2011.
2. Aoi J, Endo M, Kadomatsu T, Miyata K, Ogata A, Horiguchi H, Odagiri H, Masuda T, Fukushima S, Jinnin M, Hirakawa S, Sawa T, Akaike T, Ihn H, Oike Y. Angiopoietin-like protein 2 accelerates carcinogenesis by activating chronic inflammation and oxidative stress. Mol Cancer Res 12: 239–249, 2014.
3. +/+ mice and improves cerebral blood flow. Am J Physiol Heart Circ Physiol 302: H1330–H1339, 2012.
4. Brandes RP, Weissmann N, Schroder K. Redox-mediated signal transduction by cardiovascular Nox NADPH oxidases. J Mol Cell Cardiol 73: 70–79, 2014.
5. Buga AM, Margaritescu C, Scholz CJ, Radu E, Zelenak C, Popa- Wagner A. Transcriptomics of post-stroke angiogenesis in the aged brain. Front Aging Neurosci 6: 44, 2014.
6. Capone C, Faraco G, Park L, Cao X, Davisson RL, Iadecola C. The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension. Am J Physiol Heart Circ Physiol 300: H397–H407, 2011.
7. Chaytor AT, Edwards DH, Bakker LM, Griffith TM. Distinct hyperpolarizing and relaxant roles for gap junctions and endothelium-derived H2O2 in NO-independent relaxations of rabbit arteries. Proc Natl Acad Sci USA 100: 15212–15217, 2003.
8. Chrissobolis S, Miller AA, Drummond GR, Kemp-Harper BK, Sobey CG. Oxidative stress and endothelial dysfunction in cerebrovascular disease. Front Biosci (Landmark Ed) 16: 1733–1745, 2011.
9. Drouin A, Farhat N, Bolduc V, Thorin-Trescases N, Gillis MA, Villeneuve L, Nguyen A, Thorin E. Up-regulation of thromboxane A2 impairs cerebrovascular eNOS function in aging atherosclerotic mice. Pflügers Arch 462: 371–383, 2011.
10. Drouin A, Thorin-Trescases N, Hamel E, Falck JR, Thorin E. Endothelial nitric oxide synthase activation leads to dilatory H2O2 production in mouse cerebral arteries. Cardiovasc Res 73: 73–81, 2007.
11. Faraci FM, Lentz SR. Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 35: 345–347, 2004.
12. Farhat N, Thorin-Trescases N, Mamarbachi M, Villeneuve L, Yu C, Martel C, Duquette N, Gayda M, Nigam A, Juneau M, Allen BG, Thorin E. Angiopoietin-like 2 promotes atherogenesis in mice. J Am Heart Assoc 2: e000201, 2013.
13. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108: 1912–1916, 2003.
14. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation 108: 2034–2040, 2003.
15. Guo DF, Chenier I, Lavoie JL, Chan JS, Hamet P, Tremblay J, Chen XM, Wang DH, Inagami T. Development of hypertension and kidney hypertrophy in transgenic mice overexpressing ARAP1 gene in the kidney. Hypertension 48: 453–459, 2006.
16. Guo DF, Chenier I, Tardif V, Orlov SN, Inagami T. Type 1 angiotensin II receptor-associated protein ARAP1 binds and recycles the receptor to the plasma membrane. Biochem Biophys Res Commun 310: 1254–1265, 2003.
17. Guo DF, Sun YL, Hamet P, Inagami T. The angiotensin II type 1 receptor and receptor-associated proteins. Cell Res 11: 165–180, 2001.
18. Haas JA, Lockhart JC, Larson TS, Henrikson T, Knox FG. Natriuretic response to renal interstitial hydrostatic pressure during angiotensin II blockade. Am J Physiol Renal Fluid Electrolyte Physiol 266: F117–F119, 1994.
19. Hare JM, Stamler JS. NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest 115: 509–517, 2005.
20. Horio E, Kadomatsu T, Miyata K, Arai Y, Hosokawa K, Doi Y, Ninomiya T, Horiguchi H, Endo M, Tabata M, Tazume H, Tian Z, Takahashi O, Terada K, Takeya M, Hao H, Hirose N, Minami T, Suda T, Kiyohara Y, Ogawa H, Kaikita K, Oike Y. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Arterioscler Thromb Vasc Biol 34: 790–800, 2014.
21. Johnson DK, Schillinger KJ, Kwait DM, Hughes CV, McNamara EJ, Ishmael F, O’Donnell RW, Chang MM, Hogg MG, Dordick JS, Santhanam L, Ziegler LM, Holland JA. Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols. Endothelium 9: 191–203, 2002.
22. Krummen S, Drouin A, Gendron ME, Falck JR, Thorin E. ROSsensitive cytochrome P450 activity maintains endothelial dilatation in ageing but is transitory in dyslipidaemic mice. Br J Pharmacol 147: 897–904, 2006.
23. Lambeth JD, Neish AS. Nox enzymes and new thinking on reactive oxygen: a double-edged sword revisited. Annu Rev Pathol 9: 119–145, 2013.
24. Li X, Geary GG, Gonzales RJ, Krause DN, Duckles SP. Effect of estrogen on cerebrovascular prostaglandins is amplified in mice with dysfunctional NOS. Am J Physiol Heart Circ Physiol 287: H588–H594, 2004.
25. Mederle K, Schweda F, Kattler V, Doblinger E, Miyata K, Hocherl K, Oike Y, Castrop H. The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension. Crit Care 17: R130, 2013.
26. Milisav I, Poljsak B, Suput D. Adaptive response, evidence of crossresistance and its potential clinical use. Int J Mol Sci 13: 10771–10806, 2012.
27. Montezano AC, Touyz RM. Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies. Ann Med 44, Suppl 1: S2–S16, 2012.
28. Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31, Suppl 2: S170–S180, 2008.
29. Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24: 981–990, 2012.
30. Sun SY. N-acetylcysteine, reactive oxygen species and beyond. Cancer Biol Ther 9: 109–110, 2010.
31. Tabata M, Kadomatsu T, Fukuhara S, Miyata K, Ito Y, Endo M, Urano T, Zhu HJ, Tsukano H, Tazume H, Kaikita K, Miyashita K, Iwawaki T, Shimabukuro M, Sakaguchi K, Ito T, Nakagata N, Yamada T, Katagiri H, Kasuga M, Ando Y, Ogawa H, Mochizuki N, Itoh H, Suda T, Oike Y. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 10: 178–188, 2009.
32. Thorin E, Meerkin D, Bertrand OF, Paiement P, Joyal M, Bonan R. Influence of postangioplasty beta-irradiation on endothelial function in porcine coronary arteries. Circulation 101: 1430–1435, 2000.
33. Thorin E, Shreeve SM. Heterogeneity of vascular endothelial cells in normal and disease states. Pharmacol Ther 78: 155–166, 1998.
34. Thorin-Trescases N, Thorin E. Angiopoietin-like-2: a multifaceted protein with physiological and pathophysiological properties. Expert Rev Mol Med 16: e17, 2014.
35. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 552: 335–344, 2003.
36. Virdis A, Neves MF, Amiri F, Touyz RM, Schiffrin EL. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 22: 535–542, 2004.
37. Voghel G, Thorin-Trescases N, Farhat N, Mamarbachi AM, Villeneuve L, Fortier A, Perrault LP, Carrier M, Thorin E. Chronic treatment with N-acetyl-L-cysteine delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients. Mech Ageing Dev 129: 261–270, 2008.
38. Wattanapitayakul SK, Weinstein DM, Holycross BJ, Bauer JA. Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders. FASEB J 14: 271–278, 2000.
39. Wrona M, Wardman P. Properties of the radical intermediate obtained on oxidation of 2′,7′-dichlorodihydrofluorescein, a probe for oxidative stress. Free Radic Biol Med 41: 657–667, 2006.
40. Yu C, Luo X, Farhat N, Daneault C, Duquette N, Martel C, Lambert J, Thorin-Trescases N, Rosiers CD, Thorin E. Lack of angiopoietinlike- 2 expression limits the metabolic stress induced by a high-fat diet and maintains endothelial function in mice. J Am Heart Assoc 3: e001024, 2014.
41. Zou MH. Peroxynitrite and protein tyrosine nitration of prostacyclin synthase. Prostaglandins Other Lipid Mediat 82: 119–127, 2007.